chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Wheezing
Clinical narrative: Neck stiff; Left armpit area swollen; Armpit area tender; Heart beat a couple of times felt veryrapid; Neck sore; Itchy throat; Wheezing; Aches, hit by a truck feeling; Sweats; Sore left arm; Headache; Nausea; This is a spontaneous report from contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: E86955 or EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 12:45 (at the age of 43-years-old) as a single dose, for COVID-19 immunisation. Medical history included asthma and body mass index (BMI). The patient did not have any allergies to medications, food, or other products. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) on occasion for an unknown indication from an unknown date. The patient did not receive any other vaccine within four weeks of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the left arm on 07Mar2021 at 15:30 (at the age of 43-years-old) as single dose, for COVID-19 immunisation. On 28Mar2021 at 17:30 (also reported as night of second dose), the patient experienced sore left arm, itchy throat, wheezing (needed to use inhaler), headache, sweats, nausea, aches, hit by a truck feeling which lasted until end of day on 29Mar2021. On 30Mar2021, the patient felt better but her neck was stiff and sore and left armpit area swollen and tender and heart beat a couple of times felt very rapid. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of pain in arm, itchy throat, wheezing, headache, sweaty, nausea, pain, neck stiff, neck pain, local swelling, armpit pain and heart rate high was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph node on collarbone; painful lymph nodes on collarbones; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: unknown), via an unspecified route of administration and anatomical site on 24Mar2021 at 12:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer and blood pressure high. The patient did not have allergies to medications, food, or other products. No concomitant medications were taken by the patient. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced swollen lymph node and painful lymph nodes on collarbone. The patient did not receive any treatment for the events. The clinical outcome of the event swollen lymph node and painful lymph nodes was not recovered at the time of report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: for COVID-19 immunisation. Medical history included hypertension, bladder cancer and mitral valve prolapse, started on unknown dates. Concomitant medication included alprenolol hydrochloride (ATENENOL), atorvastatin (MANUFACTURER UNKNOWN) all taken for unknown indication, since an unspecified date. The patient was allergic to sulfanamide drugs and shrimp. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 01:00 the patient experienced swollen eyelid. The patient's eyelids were extremely swollen. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was reported that the patient didn't receive any treatment for the adverse event swollen eyelid. The clinical outcome of the event swollen eyelid was not recovered.   No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Nausea
Clinical narrative: she experienced nausea and difficulty breathing; she experienced nausea and difficulty breathing; This is a spontaneous report received from a contactable consumer (patient) reporting herself via a sales representative. A 70-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on 28Mar2021 as single dose for covid-19 immunisation. Medical history included diabetes mellitus, multiple sclerosis, hypertension and pulmonary embolism. The patient's concomitant medications were not reported. On 28Mar2021, within a few hours of her vaccine, the patient experienced nausea and difficulty breathing. Patient was on oxygen 24 hours a day. She was still having the same symptoms 24 hours later. Therapeutic measures were taken as a result of difficulty breathing. The outcome of events was not recovered.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal hypoaesthesia
Clinical narrative: An hour after receiving vaccine I started feeling numbness on my throat and on the left side of my throat.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 29-year-old) at 12:30 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 13:30, the patient experienced numbness on throat and left side of throat. No treatment was taken for any of the reported events. The clinical outcome of the event numbness throat was not recovering at the time of report.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Fatigue, Pain
Clinical narrative: no apetite; itchiness; tiredness; fever; chills; achiness; This is a spontaneous report from a contactable consumer, a patient. A 70-year-old non-pregnant female patient received second dose of BNT162b2 (Pfizer BioNTech COVID-19 mRNA Vaccine Lot no: ER8730) on 24Mar2021 at 05:15 on left arm as a single dose for COVID-19 immunisation. Facility where the COVID-19 vaccine was administered was pharmacy. Medical history was included breast cancer. The patient was allergic to tree pollens, dust, perfumes. Concomitant medications included LIPITOR. The patient previously received first dose of BNT162b2 (Pfizer BioNTech COVID-19 mRNA Vaccine Lot no: en6200) on left arm on 24Feb2021 at 04:45 AM, as a single dose for COVID-19 immunisation. The patient has not had any symptoms associated with COVID-19. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 24Mar2021, the patient experienced fever, chills and achiness. On 25Mar2021 at 07:00 AM, the patient experienced tiredness. On 26Mar2021, the patient experienced no appetite and itchiness. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of this events fever, chills, achiness, tiredness, appetite and itchiness was recovering.  No follow-up attempts are needed. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: no apetite; itchiness; tiredness; fever; chills; achiness; This is a spontaneous report from a contactable consumer, a patient. A 70-year-old non-pregnant female patient received second dose of BNT162b2 (Pfizer BioNTech COVID-19 mRNA Vaccine Lot no: ER8730) on 24Mar2021 at 05:15 on left arm as a single dose for COVID-19 immunisation. Facility where the COVID-19 vaccine was administered was pharmacy. Medical history was included breast cancer. The patient was allergic to tree pollens, dust, perfumes. Concomitant medications included LIPITOR. The patient previously received first dose of BNT162b2 (Pfizer BioNTech COVID-19 mRNA Vaccine Lot no: en6200) on left arm on 24Feb2021 at 04:45 AM, as a single dose for COVID-19 immunisation. The patient has not had any symptoms associated with COVID-19. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 24Mar2021, the patient experienced fever, chills and achiness. On 25Mar2021 at 07:00 AM, the patient experienced tiredness. On 26Mar2021, the patient experienced no appetite and itchiness. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of this events fever, chills, achiness, tiredness, appetite and itchiness was recovering.  No follow-up attempts are needed. No further information is expected
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Throat irritation
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 66-year-old-non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: UNKNOWN) via the unspecified route of administration on 23Mar2021 at 16:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patients had no medical history reported. The patient was allergic to sulfonamides. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks of the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not tested for COVID-19. On an unknown day in Mar2021, the patient experienced muscle aches and scratchy throat. The clinical outcome of the events muscle aches and scratchy throat was unknown at this time of the report.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Rash erythematous, Vertigo
Clinical narrative: Day 3 woke up with dizziness; Vertigo; Feel soreness in arm almost right after shot. Moved arm and massaged.; Developed a red rash at site for next 12 hours.; This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 25Mar2021, (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient was allergic to amoxicillin and erythromycin. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021, at 07:00, the patient felt soreness in arm almost right after shot, moved arm and massaged and also developed a red rash at site for next 12 hours. Developed a red rash at site for next 12 hours. On 27Mar2021, the patient woke up with dizziness and vertigo. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events soreness in arm, vertigo and dizziness was not resolved, while the clinical outcome of red rash was resolved. No follow-up attempts possible. No further information expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Feeling hot, Pain
Clinical narrative: Extreme fatigue/aches 2nd and 3rd day ongoing; Extreme fatigue/aches 2nd and 3rd day ongoing; Pain/heat/redness entire back of arm from shoulder to elbow ongoing at day 6; Pain/heat/redness entire back of arm from shoulder to elbow ongoing at day 6; Chills/fever 18 hrs post injection; Chills/fever 18 hrs post injection; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: ER2613), via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included discoid lupus, reflux, gallstones, pericardial effusion and osteopenia. The patient was allergic to penicillin (PCN). Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 5 mg, calcium; colecalciferol (CALCIUM 600+VITAMIN D3 400) and paracetamol (TYLENOL) 650 (units unspecified); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021, the patient experienced chills and fever, 18 hours post injection, extreme fatigue, aches, pain 2nd and 3rd day, was ongoing and pain/heat/redness entire back of arm from shoulder to elbow, was ongoing at day 6. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events chills, fever, fatigue, aches, redness and hot feeling generalized was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Extreme fatigue/aches 2nd and 3rd day ongoing; Extreme fatigue/aches 2nd and 3rd day ongoing; Pain/heat/redness entire back of arm from shoulder to elbow ongoing at day 6; Pain/heat/redness entire back of arm from shoulder to elbow ongoing at day 6; Chills/fever 18 hrs post injection; Chills/fever 18 hrs post injection; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: ER2613), via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included discoid lupus, reflux, gallstones, pericardial effusion and osteopenia. The patient was allergic to penicillin (PCN). Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 5 mg, calcium; colecalciferol (CALCIUM 600+VITAMIN D3 400) and paracetamol (TYLENOL) 650 (units unspecified); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021, the patient experienced chills and fever, 18 hours post injection, extreme fatigue, aches, pain 2nd and 3rd day, was ongoing and pain/heat/redness entire back of arm from shoulder to elbow, was ongoing at day 6. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events chills, fever, fatigue, aches, redness and hot feeling generalized was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Paraesthesia, Throat tightness
Clinical narrative: Allergic reaction - tightening in throat; lower arm/nerve pain; tingling 6 days later; This is a spontaneous report from a non-contactable consumer, the patient. A 41-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207) via an unspecified route of administration in left arm on March2021 as a single dose for COVID-19 immunisation (at the age of 41-years-old). Medical history included IBS from an unspecified date. The patient was allergic to shellfish. Patient took other medications in two weeks which included multivitamins(MANUFACTURER UNKNOWN), mentha x piperita oil (IBGARD), probiotic (FLORASTOR) from an unknown date for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other other vaccine within four weeks prior to vaccination. On an unspecified date in Mach2021 the patient experienced allergic reaction- tightening in throat, lower arm/nerve pain and tingling 6 days later. The patient did not receive any treatment for adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of allergic reaction- tightening in throat, lower arm/nerve pain and tingling was not recovered.  No follow up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pyrexia
Clinical narrative: Flu like symptoms; headache; fever; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left arm on 25Mar2021 at 09:45 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Lot Number: unknown), via unspecified route of administration on unspecified date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 00:00, the patient experienced flu like symptoms, massive headache and fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events flu like symptoms, massive headache and fever was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 07:30 (at the age of 50-years-old) as a single dose for COVID -19 immunization. Medical history and concomitant medications were not reported. The patient had a history of allergy to nuts and narcotics. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 03Mar2021 at 07:15 (at the age of 50-years-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 13:00 (second day), the patient experienced swollen underarm lymph nodes and rash in legs and arms. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of swollen lymph nodes and rash in legs and arms was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness and lightheadedness; This is a spontaneous report from a non-contactable consumer, the patient. A 49-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 07Mar2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included IgA deficiency and allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Mar2021, the patient experienced dizziness and lightheadedness persisting 2-3 post vaccine. The adverse event resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event dizziness and lightheadedness. The clinical outcome of the event dizziness and lightheadedness was not recovered at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: Rash to right facial cheek; Rash to left arm at injection site; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration to arm left on 25Mar2021 03:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism. The patient had known allergy to sulfa drugs. The patient concomitant medication included levothyroxine (MANUFACTURER UNKNOWN), liothyronine (MANUFACTURER UNKNOWN) both started since an unknown date for unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 21:00, the patient experienced rash to right facial cheek, rash to left arm at injection site. Treatment received for the adverse events was reported as no. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event facial rash and vaccination site rash was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Heart rate, Heart rate increased, Pain
Clinical narrative: Bitter taste in mouth immediately following vaccination.; Food/Drink does not taste as it normally does; Severe body aches; chills; fever; high heart rate; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old, non- pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 26Mar2021, at 16:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included neuromyelitis Optica, postural orthostatic tachycardia syndrome (POTS), narcolepsy and adult onset stills disease. The patient had a history of allergy to bananas and tree nuts and amoxicillin. Concomitant medications included eculizumab (SOLIRIS), mycophenolate mofetil (CELLCEPT), prednisone (MANUFRACTURER UNKNOWN), and carbamazepine (MANUFRACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left arm on 04Mar2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 21:00, after 5 hours of vaccination, the patient had experienced bitter taste, chills, fever, taste abnormal, high heart rate and severe body aches. it was reported as patient had bitter taste in mouth immediately following vaccination, food/drink did not taste as it normally, severe body aches, chills, fever and high heart rate. The patient did not receive any treatment for the reported events. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of bitter taste, chills, fever, taste abnormal, high heart rate and severe body aches was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Taste disorder
Clinical narrative: Bitter taste in mouth immediately following vaccination.; Food/Drink does not taste as it normally does; Severe body aches; chills; fever; high heart rate; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old, non- pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 26Mar2021, at 16:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included neuromyelitis Optica, postural orthostatic tachycardia syndrome (POTS), narcolepsy and adult onset stills disease. The patient had a history of allergy to bananas and tree nuts and amoxicillin. Concomitant medications included eculizumab (SOLIRIS), mycophenolate mofetil (CELLCEPT), prednisone (MANUFRACTURER UNKNOWN), and carbamazepine (MANUFRACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left arm on 04Mar2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 21:00, after 5 hours of vaccination, the patient had experienced bitter taste, chills, fever, taste abnormal, high heart rate and severe body aches. it was reported as patient had bitter taste in mouth immediately following vaccination, food/drink did not taste as it normally, severe body aches, chills, fever and high heart rate. The patient did not receive any treatment for the reported events. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of bitter taste, chills, fever, taste abnormal, high heart rate and severe body aches was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Fatigue, Nausea, Vaccination site bruising, Vaccination site mass
Clinical narrative: bruise injection site left arm; lump below injection site left arm; pain slightly below injection site left arm; Fatigue; facial pain right side; Nausea; This is a spontaneous report from a contactable consumer, the patient. An elderly female patient of unspecified age received second dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) as a single dose in the left arm for COVID-19 immunisation on 25Mar2021. The patients medical history was not reported. Concomitant medications included low dose acetyl salicylic acid (asa) (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR), metoprolol (MANUFACTURER UNKNOWN), estrogens conjugated; medroxyprogesterone acetate (PREMPRO), paracetamol (TYLENOL) all taken for unknown indications within two weeks of vaccination. The patient had unspecified allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) on 04Mar2021. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient experienced bruise with lump and pain slightly below injection site left arm. Fatigue and facial pain right side. Briefly nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of all the events bruise injection site left arm, facial pain right side, fatigue, lump below injection site left arm, pain slightly below injection site left arm and nausea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: bruise injection site left arm; lump below injection site left arm; pain slightly below injection site left arm; Fatigue; facial pain right side; Nausea; This is a spontaneous report from a contactable consumer, the patient. An elderly female patient of unspecified age received second dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) as a single dose in the left arm for COVID-19 immunisation on 25Mar2021. The patients medical history was not reported. Concomitant medications included low dose acetyl salicylic acid (asa) (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR), metoprolol (MANUFACTURER UNKNOWN), estrogens conjugated; medroxyprogesterone acetate (PREMPRO), paracetamol (TYLENOL) all taken for unknown indications within two weeks of vaccination. The patient had unspecified allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) on 04Mar2021. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient experienced bruise with lump and pain slightly below injection site left arm. Fatigue and facial pain right side. Briefly nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of all the events bruise injection site left arm, facial pain right side, fatigue, lump below injection site left arm, pain slightly below injection site left arm and nausea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever; Nausea; Diarrhea; Muscle soreness; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ein9210) via unspecified route of administration in left arm on 08Feb2021 at 16:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and metoprolol tartrate (LOPRESSOR); both from unknown date for unspecified indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ein9810) via unspecified route of administration in left arm on an unknown date as a single dose for COVID-19 immunisation and Penicillin on an unknown date for unspecified indication and experienced a Penicillin allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 09Feb2021 at 00:00, the patient experienced fever, nausea, diarrhea, muscle soreness and sore throat. The patient had not received any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fever, nausea, diarrhea, muscle soreness and sore throat was recovered on an unknown date in Feb2021.  No follow-up attempts are needed. No further information expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Frustration tolerance decreased, Headache
Clinical narrative: Feeling Nauseous; Have bouts of diarrhea; Dizziness/lightheadedness; Tired; Aches; Headache; Frustrated and hesitant to get the 2nd dose.; This is a spontaneous report from a non-contactable consumer, patient. A 51-year-old female non-pregnant patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the arm left on 22Mar2021 11:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergies to any medications, food or other products. The patient did not receive other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 14:30, the patient experienced nauseous, diarrhea, dizziness/light headedness, tired, aches and headache. The patient was frustrated and hesitant to get the 2nd dose. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcomes of the events nauseous, diarrhea, headache, ache, dizziness, frustration and tired were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Feeling Nauseous; Have bouts of diarrhea; Dizziness/lightheadedness; Tired; Aches; Headache; Frustrated and hesitant to get the 2nd dose.; This is a spontaneous report from a non-contactable consumer, patient. A 51-year-old female non-pregnant patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the arm left on 22Mar2021 11:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergies to any medications, food or other products. The patient did not receive other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 14:30, the patient experienced nauseous, diarrhea, dizziness/light headedness, tired, aches and headache. The patient was frustrated and hesitant to get the 2nd dose. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcomes of the events nauseous, diarrhea, headache, ache, dizziness, frustration and tired were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Swollen painful armpit left side; Swollen painful armpit left side; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04Mar2021 at 12:00 (at the age of 42-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 09:30 (at the age of 42-years-old); each as a single dose for COVID-19 immunisation. Medical history included migraine. The patient previously took CECLOR and experienced allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021 at 12:00, the patient experienced swollen painful armpit on the left side. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The clinical outcome of swollen painful armpit on the left side was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscular weakness, SARS-CoV-2 test
Clinical narrative: Muscular weakness; fatigue, all over body but mainly in lowerextremities; This is a spontaneous report received from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route administration in the right arm on 05Feb2021 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) from an unknown date for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 12Feb2021, the patient experienced muscular weakness and fatigue all over the body but mainly in lower extremities. On an unknown date, the patient had undergone the COVID-19 test which included nasal swab and the results were unknown. The patient did not receive any treatment for the reported events. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of muscular weakness and fatigue was not recovered at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Lip swelling, Paraesthesia oral
Clinical narrative: crusty; woke up to them swollen; lips started to tingle; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH; Lot number: ek9231), via an unspecified route of administration in the left arm on 19Jan2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease (CKD). The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and levothyroxine sodium (SYNTHROID), for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH; Lot number: el1284), via an unspecified route of administration in the left arm on 29Dec2020 at 11:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Jan2021, three days after the vaccine, the patient's lips started to tingle and on 23Jan2021 (reported as fourth day), the patient woke up to them swollen and crusty. She went to 4 doctors over the last 2 months and finally the derm put her on steroids that seemed to work. No one could figure out what the pain and swelling was from until they found an article about another vaccinated person that had the same adverse events. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient visited 4 different MDs over 2 months. The patient was treated with antibiotics 2x, allergy medicines, rash cream and finally steroidal cream for the events lips started to tingle, woke up to them swollen and crusty. The clinical outcomes of the events lips started to tingle, woke up to them swollen and crusty were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021352672 same reporter/drug/AE with different patient
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Erythema, Feeling abnormal, Flushing, Headache
Clinical narrative: face was red andflushed; had a warm and fuzzy numbfeeling; kind of felt weird; metallic taste; headache; face was red andflushed; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN620S) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included fibroids, asthma and pre-diabetic. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), salbutamol (ALBUTEROL), montelukast (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (TRI-LO-SPRINTEC) and vitamin b12 (MANUFACTURER UNKNOWN). The patient had a history of allergy to penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Mar2021 at 11:45, the patient felt her face was red and flushed and had a warm and fuzzy numb feeling, kind of felt weird, and had a metallic taste. The patient also experienced headache all day and the next day. Since the vaccination, the patient had been tested for COVID-19 which included a COVID-19 virus test on 26Mar2021 and the result was pending. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face was red and flushed, numbness, weird feeling, metallic taste was resolved on 23Mar2021 at 12:45 while the clinical outcome of the event headache was resolved on 24Mar2021.  No follow-up attempts are needed. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: face was red andflushed; had a warm and fuzzy numbfeeling; kind of felt weird; metallic taste; headache; face was red andflushed; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN620S) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included fibroids, asthma and pre-diabetic. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), salbutamol (ALBUTEROL), montelukast (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (TRI-LO-SPRINTEC) and vitamin b12 (MANUFACTURER UNKNOWN). The patient had a history of allergy to penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Mar2021 at 11:45, the patient felt her face was red and flushed and had a warm and fuzzy numb feeling, kind of felt weird, and had a metallic taste. The patient also experienced headache all day and the next day. Since the vaccination, the patient had been tested for COVID-19 which included a COVID-19 virus test on 26Mar2021 and the result was pending. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face was red and flushed, numbness, weird feeling, metallic taste was resolved on 23Mar2021 at 12:45 while the clinical outcome of the event headache was resolved on 24Mar2021.  No follow-up attempts are needed. No further information expected.